Cargando…
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients
The complex network of etiological factors, signals and tissue responses involved in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) cannot be successfully targeted by a single therapeutic agent. Multimodal approaches to the therapy of CP/CPPS have been and are currently being tested, as...
Autores principales: | MAGRI, VITTORIO, MARRAS, EMANUELA, RESTELLI, ANTONELLA, WAGENLEHNER, FLORIAN M.E., PERLETTI, GIANPAOLO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316954/ https://www.ncbi.nlm.nih.gov/pubmed/25667610 http://dx.doi.org/10.3892/etm.2014.2152 |
Ejemplares similares
-
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up
por: Magri, Vittorio, et al.
Publicado: (2016) -
Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
por: MAGRI, V., et al.
Publicado: (2013) -
Using the UPOINT system to manage men with chronic pelvic pain syndrome
por: Bryk, Darren J., et al.
Publicado: (2021) -
Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study
por: Guan, Xiao, et al.
Publicado: (2015) -
Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study
por: Krakhotkin, Denis V., et al.
Publicado: (2019)